Abstract: The present invention relates to method for the treatment of allergic rhinitis comprising: administrating to a patient in need thereof a pharmaceutical formulation comprising a compound for formula (I) or a salt thereof, and an anti-inflammatory glucocorticoid compound of formula (II) or a solvate thereof.

Abstract: The present invention relates to pharmaceutical formulations comprising an anti-inflammatory glucocorticoid compound of formula (II), (III), (IV) or a solvate thereof and a compound for formula (I) or a salt or solvate thereof. The present invention also relates to therapeutic uses thereof, particularly for the treatment of inflammatory and allergic conditions, specifically rhinitis.

Abstract: According to the present invention there is provided an inhalation device comprising plural doses of medicament in powder form, wherein the medicament is a pharmaceutical formulation comprising salmeterol or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof and an anticholinergic agent or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof, and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients.

Abstract: The present invention is concerned with pharmaceutical formulations comprising a combination of salmeterol and ipratropium and the use of such formulations in medicine, particularly in the prophylaxis and treatment of respiratory diseases.

Abstract: Epoxide materials suitable for use in flexible adhesives are prepared by reacting a diene, such as butadiene or isoprene, with an electron donor, typically an alkali metal, in the presence of a polyepoxide normally in a molar ratio diene:polyepoxide of less than 3:1. The polyepoxide is typically a conventional epoxy resin such as DGBA. The product normally separates into two phases, the upper of which comprises epoxy-terminated diene oligomers with degrees of polymerization of about 6 to 14. This separation may be avoided by incorporating a minor proportion of acrylonitrile into the product by addition to either the original diene or the anionic living polymer immediately before hydrolysis. The products may be cured with conventional epoxide curing agents to give an internally flexibilized adhesive having useful combinations of tensile and shear strengths.